Brachytherapy for Prostate Cancer 2017

733 / 923

Teaching Course Dublin 2014
• 38/2050 (2%) patients underwent minimal TUR-P.
• 7/38 (18%) with incontinence.
• 2/24 (8%) against 5/14 (36%) with incontinence in
case TUR-P was performed <1 or > 2years after
implant.
• No correlation of incontinence with D90 prostate or
D30 urethra or dose to 5cm2 urethra.